Monitor for prospectus supplements indicating actual takedowns under the shelf or ATM. Any announced offering of size >$5M would likely pressure XLO shares given the small market cap. Watch for accelerated shelf filings or overnight offerings.
Price Chart
Executive Summary
Xilio Therapeutics' S-3 shelf registration (File No. 333-295785) became effective on May 29, 2026, allowing the company to offer up to $250M in securities including a $17.22M ATM facility with Leerink Partners. This gives Xilio immediate access to equity capital markets, creating potential dilution overhang for existing shareholders.
Key Facts
- Shelf registration effective May 29, 2026 under File No. 333-295785
- Up to $250M in securities registered (common, preferred, debt, units, warrants)
- Includes $17.22M ATM facility with Leerink Partners
- Company has $56M market cap — potential dilution is significant relative to current equity value
- Prior S-3/A (filed May 27) noted $72.5M net tangible book value as of March 31, 2026
Financial Impact
Up to $250M in securities can be sold; $17.22M ATM facility represents ~31% of current $56M market cap
Risk Factors
- Immediate dilution risk if company draws on ATM or conducts follow-on offering
- Shelf overhang may cap upside until clarity on capital needs emerges
- Biotech sector capital market conditions could influence timing and size of offerings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001811 |
| Document: 9999999995-26-001811-index.html | 9999999995-26-001811 |
| Document: 9999999995-26-001811.txt | 9999999995-26-001811 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | Press Release | — | awaiting T+5 | — | — |
Aug 12, 2026 10w ago | 8-K | $9.05 $9.41 | ▲ +3.98% | ▲ +4.42% | $8.30 (−8.29%) |
Aug 12, 2026 10w ago | Press Release | $9.05 $9.41 | ▲ +3.98% | ▲ +4.42% | $8.30 (−8.29%) |
Jun 1, 2026 21w ago | EFFECT | $8.25 $7.70 | ▲ +6.67% | ▲ +3.92% | $8.30 (−0.61%) |
May 27, 2026 21w ago | S-3/A | $8.52 $8.15 | ▼ −4.40% | ▼ −4.35% | $8.30 (−2.58%) |
May 12, 2026 23w ago | 8-K | $7.73 $8.15 | ▲ +5.43% | ▲ +5.36% | $8.30 (+7.37%) |
May 12, 2026 23w ago | Press Release | $7.73 $8.15 | ▲ +5.43% | ▲ +5.36% | $8.30 (+7.37%) |
Apr 17, 2026 27w ago | Press Release | $8.45 $8.18 | ▼ −3.20% | ▼ −4.11% | $8.30 (−1.78%) |
Apr 16, 2026 27w ago | 3 | $8.57 $8.31 | ▼ −3.03% | ▼ −3.59% | $8.30 (−3.15%) |
Apr 16, 2026 27w ago | 8-K | $8.35 $8.47 | ▲ +1.44% | ▲ +0.45% | $8.30 (−0.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers